PapersPMID:40485009
Treatment of Hypovitaminosis D With Cholecalciferol in Dogs With Protein-Losing Enteropathies: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.
What moved
1 findingHow to read these marks →- Increases serum 25-hydroxyvitamin D concentration
very limitedreplicated ×35
“Dogs with PLE treated with cholecalciferol had higher 25OHD concentrations at T2 compared to dogs treated with placebo (225 nmol/L, range 72-434 vs. 80 nmol/L, range 31-254 nmol/L; p = 0.004).”
- Study
- animal · not in humans
- Duration
- 4 weeks
- Dose studied
- 400 IU/kg cholecalciferol PO daily for 6 weeks
- Population
- dogs with protein-losing enteropathy and decreased serum 25OHD, receiving standard PLE therapy in both arms
Study record
- Design
- randomised controlled trial
- Species
- animal
- Population
- 28 dogs with protein-losing enteropathy and decreased serum 25OHD
- Participants
- 28
- Comparator
- not stated in the paper / placebo
- Duration
- 42 days
- Endpoints measured
- 3
calciol